-+ 0.00%
-+ 0.00%
-+ 0.00%

Cumberland Pharma wins FDA approval expanding Caldolor label to include postoperative pain

PUBT·04/16/2026 13:06:42
Listen to the news
Cumberland Pharma wins FDA approval expanding Caldolor label to include postoperative pain
  • Cumberland Pharmaceuticals received FDA clearance for an expanded indication for Caldolor (ibuprofen) Injection to include postoperative pain.
  • Label now covers adult and pediatric patients ages 3 months and older for pain management, including perioperative use.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cumberland Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL35788) on April 16, 2026, and is solely responsible for the information contained therein.